MarketInOut Stock Screener Log In | Sign Up
 

ADMA Biologics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/06/2026 16:00
ADMA Biologics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,264.48 mln
Float215 mln
Earnings Date11/11/2026

EPS

0.70
Decent

P / E

14.54
Fair value

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.37
Borderline

Relative Strength

89 / 100
Strongly outperforming

Debt / Equity

0.50
Moderate leverage

Business Description

ADMA Biologics is a U.S.-based company that produces and sells medicines made from human plasma, primarily used to help patients with weakened immune systems or serious infections like Hepatitis B. Founded in 2004 and based in Ramsey, New Jersey, the company runs its own plasma collection centers and manufacturing operations to support its product line. Its treatments reach patients through wholesalers, specialty pharmacies, and distributors across the United States and in other countries.

Key Fundamentals

EPS0.70
P/E14.54
ROE40.13
RPS2.18
ROIC36.35
ROA27.17
Interest Cover24.53
EBITDA, mln233
EV / EBITDA10.11
EV / EBIT10.46
Revenue, mln512
EV / Revenue4.60

Quote Details

Last 10.18
Change 0.07 (0.69%)
Open 10.20
Volume 2,088,971
Turnover 21,265,726
Average Volume 3,274,282

Financial Ratios

Pre-Tax Profit Margin42
Leverage Ratio1.68
Current Ratio6.97
Price / Book5.54
Price / Tangible Book5.60
Price / Cash Flow16.88
Price / Free Cash Flow20.55
Debt / Equity0.50
Price / Sales4.75

Financial Strength

Altman Z-Score7.32
Piotroski F-Score 5 / 9
Beneish M-Score-2.37
Price to Intrinsic Value12.86
Price to Graham Number1.87
Short Ratio12.18
Short % of Float13.32

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.21% 76 / 100   
1 Month 5.82% 86 / 100   
2 Months 21.62% 91 / 100   
6 Months 9.94% 65 / 100   
1 Year -30.56% 24 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us